Industry Insights

Federal Court Blocks Corporate Transparency Act Nationwide

On December 3, 2024, a United States District Court for the Eastern District of Texas ruling blocked the Corporate Transparency Act (“CTA”) nationwide.

In the opinion, the CTA was found to be “likely unconstitutional” and that its looming December 31, 2024, deadline would cause irreparable harm to companies that were required to comply.

Learn more here.

U.S. Department of Labor July 2024 Overtime Salary Threshold Rule is Vacated – What Should Employers Do Now?

On November 15, 2024, the U.S. District Court for the Eastern District of Texas issued a nationwide injunction halting the Department of Labor's July 2024 final rule on overtime salary thresholds. The ruling has significant implications for employers across the country.

Learn more in an article by Christopher Mayer and Lauren Rutkowski here.

Year-End Check-Up for Ophthalmology and Optometry Practices: Are You Compliant with the FTC’s Updated Eyeglass Rule?

Updates to the FTC’s Ophthalmic Practice Rules, also known as the "Eyeglass Rule," went into effect in late September. The rule requires ophthalmologists and optometrists to automatically provide patients with a free copy of their prescription after an eye exam.

Theresa DiGuglielmo and Lauren Rutkowski address key updates to the rule here.

NJ Provider Alert: Medicaid’s Recovery Edict and How It Impacts Your Practice

New Jersey's Medicaid Fraud Division has issued new guidelines limiting Managed Care Organizations from negotiating overpayment settlements unless reductions are merit-based. This hardline stance emphasizes the need for compliance among medical practices with high Medicaid patient volumes, as coding or billing mistakes could lead to significant financial penalties.

Guillermo Beades and Phoebe Nelson examine this directive and how it will impact practices here.

Provider Alert: A New Law will Restrict Noncompete Covenants with Pennsylvania-Based Health Care Workers Starting on January 1, 2025

A new law, the Pennsylvania Fair Contracting for Health Care Practitioners Act, will void certain noncompete covenants for healthcare practitioners starting on January 1, 2025. Accordingly, it is imperative that impacted Pennsylvania providers consider the Act’s requirements before entering into new noncompete covenants with practitioners. 

Charles Newman, Christopher Mayer and Samuel Green provide an overview of the new law in a recent article. Read here.

On-Demand Webinar

Balancing Physician Rights & Hospital Actions in Harassment Cases 

In healthcare, few topics are as complex as the intersection of physician due process rights and hospital obligations in harassment cases. Frier Levitt partners Todd Brower, Alex Keoskey, and Christopher Mayer provide an in-depth exploration of these critical issues in our latest webinar.

Click the image below to view the webinar:

Subscribe to our YouTube:

Newsworthy

Alex Keoskey Featured in Healthcare Risk Management “Loss of Chance Doctrine Claims Can Be Avoided”

Frier Levitt Partners Published in Medical Economics “How to Prevent and Address Harassment Complaints: Balancing Physician Rights and Hospital Actions”

Jason Silberberg Published in New York Law Journal “Combatting Agency Overreach in Healthcare Law and Policy”

Frier Levitt’s Government Investigations, Litigation & White-Collar Defense Group is comprised of seasoned professionals, including a former Assistant United States Attorney, Deputy Attorneys General, and healthcare litigators who have decades of experience defending corporate entities, executives, and healthcare and life sciences professionals for alleged healthcare violations.

Our attorneys bring a wealth of firsthand knowledge of how government agencies conduct investigations and prosecute cases. This litigation-centric experience and skillset, combined with the firm’s extensive regulatory, transactional, and clinical knowledge, work to resolve such cases successfully, often doing so before public charges are filed.

Contact Frier Levitt to speak to an attorney about regulatory concerns, government inquiries, subpoena and CID defense, as well as litigation defense.

Learn more about Frier Levitt's Government Investigations, Litigation & White-Collar Defense here.

Very truly yours,

Daniel B. Frier, Esq.

Co-Founding Partner

Frier Levitt

dbfrier@frierlevitt.com

973.618.1660

Bio | LinkedIn